Pune, India -- (SBWIRE) -- 11/05/2018 -- Transcriptomics Technologies Market Research Report
The Transcriptomics Technologies market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers/players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
The Transcriptomics Technologies market is estimated to represent a global market of USD 2.69 billion by 2017 with a growth rate of 5.5%.
Transcriptomics is defined as the study of RNA transcripts that are produced by the genome under specific conditions in specified cell bodies. These transcriptomics datasets are products by various high-throughput methods such as next-generation sequencing and microarray analysis as it usually demands quantitative measurement of thousands of genes. Primary aim behind transcriptome analysis is to identify differentially expressed genes and to gain proper understanding of disease condition.
Get a Sample PDF Report: https://www.garnerinsights.com/Transcriptomics-Technologies-Market-Study-and-Trend-Research-2014-2025#request-sample
Genome Analyzer by Illumina, Inc., AB SOLiD by Life Technologies Corporation, and Roche 454 and HeliScope by Helicos Biotechnologies are the technologically updated system available in the market currently. Furthermore, growing demand for personalized medicine ensures a potential opportunity in the commercialization of transcriptome research results. Despite the industry is on a high growth trajectory, some potential threats exist such as lack of skilled personnel and efficient data tools that will likely to restraint the growth prospects going forward.
In terms of technology, the industry is divided into Polymerase Chain Reaction (PCR), Gene Regulation Technologies, Microarray, and Next Generation Sequencing. PCR (also termed as molecular photocopying) captured the highest share among the different technologies owing to its associated advantages such as high sensitivity, better precision, and cost-effectiveness.
The high sensitivity of this technique enables the amplification of very small amounts of genetic material samples. Application segment is categorized as Drug Discovery & Research, Clinical Diagnostics, Bioinformatics and Comparative Transcriptomics. Adoption of transcriptomics in drug discovery and research is increasing rapidly and thus this application holds the largest revenue share throughout the review period.
The report studies the global market size of the Transcriptomics Technologies in key regions like North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa focuses on the consumption of Transcriptomics Technologies in these regions.
The industry is consolidated in nature, where a limited number of players control significant revenue share. Key players such as Life Technologies Corporation, Illumina, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., and Affymetrix, Inc. emerged as the prominent players in this market. Of these, Agilent holds highest share (over 20%) of the global transcriptomics market.
Still, in such a consolidated landscape, a large number of small-scale or large-scale players are competing to capture large customer base. In February 2015, Beckman Coulter Inc. launched the service of processing degraded RNA samples of the mouse, human, rat, and plants. This is likely to enhance the clarity on providing a more complete transcriptome analysis.
Get Discount on this Report: https://www.garnerinsights.com/Transcriptomics-Technologies-Market-Study-and-Trend-Research-2014-2025#discount
TARGET AUDIENCE
Traders, Distributors, and Suppliers
Manufacturers
Hospitals
Government and Regional Agencies and Research Organizations
Consultants
Distributors
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY TECHNOLOGY
Polymerase Chain Reaction (PCR)
Gene Regulation Technologies
Microarray
Next Generation Sequencing
Research objectives:-
To study and analyze the global Transcriptomics Technologies consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2032.
To understand the structure of the Transcriptomics Technologies market by identifying its various sub-segments.
Focuses on the key global Transcriptomics Technologies manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
To analyze the Transcriptomics Technologies with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Transcriptomics Technologies submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Overall the report offers detailed coverage of Transcriptomics Technologies industry and presents main market trends. This research gives historical and forecasts market size, demand and production forecasts, end use demand details, price trends, and company shares of the leading Transcriptomics Technologies producers to provide exhaustive coverage of the market.
Read Full Report with TOC: https://www.garnerinsights.com/Transcriptomics-Technologies-Market-Study-and-Trend-Research-2014-2025
If you are interested in more information, please contact our media team at sales@garnerinsights.com